It seems there was an error, as the content you provided is marked as "undefined." Please provide specific content for summarization.
AZN has been in the news recently: The FDA has approved AstraZeneca's Koselugo for adults with neurofibromatosis type 1 and inoperable plexiform neurofibromas. Additionally, AstraZeneca, along with Eli Lilly and Merck, will invest $120 million to develop Virginia's Center for Advanced Pharmaceutical Manufacturing, which is expected to create thousands of jobs.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.